ABUS vs ZBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 03, 2026

ABUS

36.2
AI Score
VS
ZBIO Wins

ZBIO

67.3
AI Score

Investment Advisor Scores

ABUS

36score
Recommendation
AVOID NEW MONEY

ZBIO

67score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ABUS ZBIO Winner
Forward P/E 10.2459 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -90.6% -100.0% ABUS
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 36.2/100 67.3/100 ZBIO
Profit Margin 84.2% 0.0% ABUS
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD ZBIO

Relative Price Performance (Last 90 Days)

ABUS 1M: -12.7% · 3M: -10.5% ZBIO 1M: -14.6% · 3M: +7.0%

Current Technical Phase

ABUS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 28

RSI (14): 28.0 · Price: $4.45

ZBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 41.9 · Price: $28.30

Fundamentals Snapshot

Metric ABUS ZBIO
Market Cap — —
Forward P/E -40.1 -6.1
Trailing P/E 6.1 —
Revenue (TTM) — —
Revenue Growth -0.9% -1.0%
Gross Margin 0.9% -212.5%
Operating Margin -5.7% -77.7%
EPS 0.75 -10.00
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, ZBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.